UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
Abstract Background: A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs)…
Abstract Background: A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs)…
Abstract This cross-sectional study analyzes changes in adolescent cannabis use and perceptions of cannabis harm associated with the legalization of…
Abstract The detection of cannabis and cannabis‐related products is a critical task for forensic laboratories and law enforcement agencies, given…
Abstract Nonclinical testing to predict the abuse potential of central nervous system (CNS) drug candidates is a mandatory part of…
Abstract Predicting outcomes in individuals at clinical high risk (CHR) of developing psychosis remains challenging using clinical metrics alone. The…
Abstract Background: Intracerebral hemorrhage (ICH) is a leading cause of death and disability worldwide. Following the initial mechanical injury caused…
Abstract This review focuses on Cannabis Hyperemesis Syndrome (CHS) in youth, a condition linked to chronic cannabis use and characterized…
Abstract Diabetes mellitus (DM) is a chronic metabolic disorder marked by sustained hyperglycemia. These disturbances contribute to extensive damage across…
Abstract Cannabinoids, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), have been increasingly studied for their therapeutic applications in various medical fields.…
Abstract This study evaluates the impact of dietary supplementation with hemp-based polyunsaturated fatty acids (PUFAs) on the membrane lipid profiles…